Tio2 column chromatography

Show results for

Proteomics (381)
Unknown (4)
Metabolomics (3)

Organisms

Allexis (380)
Arabidopsis thaliana (380)
Bos taurus (380)
Callinectes sapidus (380)
Drosophila melanogaster (380)
Entamoeba histolytica HM-1:IMSS-A (380)
Escherichia coli (380)
Homo sapiens (380)
Leishmania major strain Friedlin (380)
Listeria monocytogenes (380)
Medicago truncatula (380)
Meleagris gallopavo (380)
Methylohalobius crimeensis 10Ki (380)
Mus musculus (380)
Rattus norvegicus (380)
Saccharomyces cerevisiae (380)
Schizosaccharomyces pombe (380)
Shigella (380)
Shigella flexneri (380)
Sinorhizobium meliloti BL225C (380)
Solanum tuberosum (380)
Staphylococcus aureus (380)
Sus scrofa domesticus (380)
Zea mays (380)
Cyanophora paradoxa (379)
Ensifer adhaerens (379)
Histomonas meleagridis (379)
Mycobacterium tuberculosis (379)
Pseudomonas putida KT2440 (379)
Schizosaccharomyces pombe 972h- (379)

Repository

pride (380)
MetaboLights (3)
MassIVE (1)

Tissue

Cell culture (89)
Epithelial cell (33)
Brain (16)
Heart (15)
Liver (13)
Permanent cell line cell (12)
Cell suspension culture (11)
Fibroblast (11)
Blood cell (10)
Lung (9)
Blood (8)
Plant cell (8)
Skin (8)
T cell (8)
B cell (7)
Bone marrow (7)
Embryonic stem cell (7)
Leaf (7)
Hepatocyte (6)
Endothelial cell (5)
Kidney (5)
Macrophage (5)
Myotube (5)
Placenta (5)
Primary cell (5)
Whole body (5)
HeLa cell (4)
Lymph node (4)
Mammary gland epithelial cell (4)
Root (4)

Disease

Disease free (12)
Acute leukemia (11)
Breast cancer (10)
Colon cancer (6)
Plasmodium falciparum malaria (5)
Lung cancer (4)
Osteosarcoma (4)
Alzheimer's disease (3)
Cardiovascular system disease (3)
Melanoma (3)
Mixed disorder as reaction to stress (3)
Prostate adenocarcinoma (3)
Acute myeloid leukemia (2)
Amyotrophic lateral sclerosis (2)
Cervix carcinoma (2)
Chagas disease (2)
Lung adenocarcinoma (2)
Lymphoma (2)
Type 2 diabetes mellitus (2)
Albright's hereditary osteodystrophy (1)
Aortic valve stenosis (1)
Arrhythmogenic right ventricular cardiomyopathy (1)
Asthma (1)
Barrett's esophagus (1)
Burkitt lymphoma (1)
Crohn's disease (1)
Down syndrome (1)
Obesity (1)
Parkinson's disease (1)
Simpson-Golabi-Behmel syndrome type 1 (1)

Technology Type

Mass Spectrometry (380)
Shotgun proteomics (263)
Bottom-up proteomics (71)
Data-dependent acquisition (42)
Affinity purification coupled with mass spectrometry proteomics (25)
Data-independent acquisition (12)
SWATH MS (10)
Top-down proteomics (7)
Gel-based experiment (6)
Chemical cross-linking coupled with mass spectrometry proteomics (5)
SRM/MRM (3)
Mass spectrometry (2)
Mass spectrometry assay (1)
Metaproteomics (1)

Instrument Platform

Thermo Scientific Orbitrap Velos 2 (1)
Exactive (Thermo Scientific) (1)
Liquid Chromatography MS - alternating - reverse-phase (1)
Liquid Chromatography MS - positive - reverse phase (1)

Publication Date

2022 (51)
2025 (47)
2021 (41)
2023 (38)
2026 (36)
2024 (35)
2020 (31)
2019 (31)
2016 (18)
2018 (18)
2015 (16)
2017 (13)
2014 (6)
2013 (2)
2012 (1)

Metabolite Name

(2S)-1-[(2S)-2-[(5-methoxy-1-methylindole-2-carbonyl)amino]-3-methylbutanoyl]pyrrolidine-2-carboxylic acid (1)
Methyl 2-[(4-hydroxyphenyl)methylene]-3-oxobenzo[b]furan-5-carboxylate (1)
(19E)-4-Ethyl-2,16-Didehydrocur-19-En-4-Ium-17-Al (1)
1H,1H,2H,2H-Perfluorohexanol (1)
Ethyl 5-hydroxy-2-methyl-1-[2-(4-propylphenoxy)ethyl]benzo[g]indole-3-carboxyl ate (1)
(E)-N-butyl-N-(1-(cyclohexylamino)-1-oxobutan-2-yl)but-2-enamide (1)
Ethyl 3-nitrocinnamate (1)
NCGC00386084-01_C23H32N2O3_ (1)
2-Chloro-N-[2-(5-Methoxy-2-Methyl-1H-Indol-3-Yl)Ethyl]-5-Nitrobenzamide (1)
5-[(E)-3-hydroxybut-1-enyl]-4-[4-[(E)-3-oxobut-1-enyl]anilino]oxolan-2-one (1)
5-chloro-2,4-dihydroxy-3-[(E)-4-hydroxy-3-methyl-5-(1,2,6-trimethyl-3-oxocyclohexyl)pent-2-enyl]-6-methylbenzaldehyde (1)
3,5-Dichlor-lecanorsaeure-methylester (1)
Dihydroyashabushiketol (1)
9-methyl-8-{[3-(trifluoromethyl)phenyl]methylthio}hydropurin-6-one (1)
(1S,4R,5S,23S,26S)-26-hydroxy-4,5,13,13,15,15,31,31-octamethyl-14,32,33-trioxa-7-azanonacyclo[28.2.1.01,27.04,26.05,23.06,21.08,20.010,18.011,16]tritriaconta-6(21),8(20),9,11,16,18,27-heptaen-29-one (1)
3-{3-[(3-chloro-4-fluorophenyl)amino]propanoyl}chromen-2-one (1)
Iodohippuric acid (1)
Mmv676470 (1)
14-Chloro-2, 8, 10-trihydroxy-3, 11(13)-guaiadien-12, 6-olide (1)
N-(4-fluorophenyl)-2-(6-oxo-9-phenylhydropurin-8-ylthio)acetamide (1)
3-Hydroxydesloratadine (1)
3,3-dimethyl-11-(4-prop-2-ynyloxyphenyl)-2,3,4-trihydro-5H,10H,11H-benzo[1,2-f ]benzo[b]1,4-diazepin-1-one (1)
2-(2-acetylbenzimidazolyl)-N-[2-(3,4-dimethoxyphenyl)ethyl]acetamide (1)
Diphenidol Hydrochloride (1)
Mls001148620 (1)
6-Hydroxyangolensic acid methyl ester (1)
Rev 5901 (1)
Methyl 3-phenyl-2-(phenylformamido)propanoate (1)
2-[2-oxo-4-(piperidylcarbonyl)hydroquinolyl]-N-(2-phenylethyl)acetamide (1)
Pheniramine maleate salt (1)

Modification

2x(15)N labeled L-lysine (5)
4x(15)N labeled L-arginine (4)
4 (1)
4-tetrahydrothiazine-3-carboxylic acid (1)
Not available (1)

Release Date

2025 (1)
2022 (1)
2020 (1)
2012 (1)

Lab affiliation

Institute of Molecular Biology (IMB), Mainz, Germany (5)
DIMEVET Università degli Studi di Milano (3)
Department of Biochemistry and Functional Proteomics, Institute of Biology II, Faculty of Biology and BIOSS Centre for Biological Signalling Studies, University of Freiburg, 79104 Freiburg im Breisgau, Germany (3)
Department of Cell and Molecular Biology, College of Medicine, Chang Gung University, Taoyuan, Taiwan (3)
OncoProteomics Laboratory, Dept of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands (3)
1. Barts Cancer Institute Queen Mary, University of London John Vane Science Centre, Charterhouse Square, London EC1M 6BQ 2. Instituto de Parasitología y Biomedicina López-Neyra, Consejo Superior de Investigaciones Científicas (CSIC), Granada, 18016, Spain (2)
Associate Professor, Whitehead Institute for Biomedical Research and Massachusetts Institute of Technology (2)
BK21 FOUR Community-Based Intelligent Novel Drug Discovery Education Unit, College of Pharmacy and Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu 41566, Republic of Korea (2)
Bioanalytical Mass Spectrometry Group, Max Planck Institute for Multidisciplinary Sciences, Germany (2)
CRUK Beatson Institute (2)
Center for Molecular Medicine University Medical Center Utrecht Utrecht 3584CG The Netherlands (2)
College of Biomedical Engineering & Instrument Science, Zhejiang University (2)
Department of Dermatology, Medical University of Vienna (2)
Department of Radiation Oncology, University of Texas Health Science Center at San Antonio (2)
Director, Centre for Proteome Research Department of Biochemistry & Systems Biology Institute of Systems, Molecular & Integrative Biology University of Liverpool Crown Street, Liverpool L69 7ZB +44 151 795 4424 (2)
Functional Genomics Laboratory, Carlos Chagas Institute, Fiocruz, Curitiba, Parana, Brazil (2)
Helmholtz-Centre for Environmental Research – UFZ, Department of Molecular Toxicology (2)
Institute for Clinical Biochemistry and Pathobiochemistry German Diabetes Center (DDZ) Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf Auf´m Hennekamp 65 40225 Düsseldorf Germany (2)
Institute of Animal Sciences, Chinese Academy of Agricultural Sciences (2)
Institute of Bioinformatics , International Technology Park, Bangalore, India (2)
Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch (2)
Mass Spectrometry Facility, Max Perutz Labs, University of Vienna, Vienna BioCenter, Dr. Bohr-Gasse 9, 1030 Vienna, Austria (2)
McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University, Baltimore, Maryland 21205 USA (2)
Plateforme protéomique 3P5-Necker, Université Paris Descartes - Structure Fédérative de Recherche Necker, INSERM US24/CNRS UMS3633, Paris 75014, France (2)
Proteomics Core Facility and Research Group Proteomics, CEITEC-MU, Masaryk University, Brno, Czech Republic (2)
Proteomics Unit Navarrabiomed, Pamplona, Spain (2)
School of Life Sciences, University of Warwick, Coventry, United Kingdom (2)
Shanghai Hoogen Biotechnology Co., Ltd. (2)
The Francis Crick Institute (2)
1) Department of Biology, Institute of Molecular Systems Biology, ETH Zurich, Switzerland 2) Faculty of Science, University of Zurich, Zurich, Switzerland (1)

Previous page
1 / 39
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 39
Next page

Sort by:

Relevance

Page size

Standard Pressure LC-MS/MS Using 1.9um C18 Particles Column at Room Temperature

Although the benefits of reduction of the size of reversed phase particles are established to provide increased sequencing depth and improved chromatography in LCMS experiments, the wide-scale adoption of optimally sized small particles in reversed-phase columns has been hampered by the necessity fo...

ORGANISM(S): Homo sapiens (Human)

2022-02-28 | PXD002895 | Pride

Fe-IMAC column based phospho enrichment

Fe-IMAC columns for robust and reproducible phosphopeptide ernichment, comparison to TiO2 batch and Ti-IMAC tip enrichment, large scale phosphoproteomics coupling Fe-IMAC column pre-enrichment to subsequent hSAX separation

ORGANISM(S): Homo sapiens (Human)

2015-08-19 | PXD001060 | Pride

Hsax Tio2 Ti-imac Ptm Phospho Fe-imac

p38-MAPK recruits the proteolysis pathways in Caenorhabditis elegans during bacterial infection

TiO2 column chromatography, MALDI-ToF-MS, SUMOylation, Coimmunoprecipitation and LC-MS/MS

ORGANISM(S): Caenorhabditis elegans

2022-04-06 | PXD019172 | Pride

Sumoylation Tio2 column chromatography Maldi-tof-ms Coimmunoprecipitation and lc-ms/ms

Illuminating the dark space of neutral glycosphingolipidome by selective enrichment and profiling at multi-structural levels

Glycosphingolipids (GSLs) are essential components of cell membranes, particularly enriched in the nervous system. Altered molecular distributions of GSLs are increasingly associated with human diseases, emphasizing the significance of lipidomic profiling. Traditional GSL analysis methods are ham...

2024-06-25 | MTBLS10400 | MetaboLights

Phosphoproteome enrichment strategy using complementary chemistries of Fe-NTA and TiO2 followed by LC-MS/MS

The global phosphoproteome analysis by liquid chromatography-mass spectrometry (LC-MS) has emerged as an important tool to study cell signalling. However, the coverage of phosphoproteome by LC-MS is limited despite various approaches for phosphoprotein enrichment. Studies in literature have exploite...

ORGANISM(S): Homo sapiens (Human)

2025-05-06 | PXD050933 | Pride

Affinity chromatography Phosphoproteins Enrichment Lc-ms/ms

Fully automated multifunctional ultrahigh pressure liquid chromatography system for advanced proteome analyses.

Not available

S-EPMC3412908 | biostudies-literature

Phosphoproteome enrichment strategy using complementary chemistries of Fe-NTA and TiO2 followed by LC-MS/MS

ORGANISM(S): Danio rerio (Zebrafish) (Brachydanio rerio) Cercopithecus aethiops (Green monkey) (Grivet) Pinus radiata (Monterey pine) Drosophila melanogaster (Fruit fly) Caenorhabditis elegans Dictyostelium discoideum (Slime mold) Cicer arietinum (Chickpea) (Garbanzo) Bos taurus (Bovine) Candida albicans (Yeast) Homo sapiens (Human) Brassica oleracea var. botrytis (Cauliflower) Bombyx mori (Silk moth) Brassica napus (Rape)

2025-10-30 | PXD057032 | Pride

Affinity chromatography Phosphoproteins Enrichment Lc-ms/ms

Interaction of TiO2 nanoparticles with lung fluid proteins and the resulting macrophage inflammatory response

Inhalation is a major nanoparticle exposure pathway. Following inhalation, nanoparticles first interact with the lung lining fluid, a complex mixture of proteins, lipids, and mucins. We measure the concentration and composition of lung fluid proteins adsorbed on the surface of titanium dioxide (TiO2...

ORGANISM(S): Mus musculus (Mouse)

2023-11-10 | PXD041036 | Pride

Titanium dioxide Bronchoalveolar lavage Nanoparticles Inhalation Murine Protein corona

JEC21 CN phosphoproteomic study, Yadav and Heitman

Label free quantititative phosphoproteomics analysis following TiO2 enrichment, nanoscale capillary chromatography and high resolution tandem mass spectrometry.

ORGANISM(S): Cryptococcus neoformans var. neoformans JEC21

2025-08-21 | PXD059891 | Pride

Phosphoproteomics Label free

Macro-porous Reversed Phase Separation of Proteins Combined with Reversed Phase Separation of Phosphopeptides and Tandem Mass Spectrometry for Profiling the Phosphoproteome of MDA-MB-231 cells

A new method of combining macro-porous reversed phase (mRP) protein fractionation with reversed phase liquid chromatography (RPLC) peptide separation tandem mass spectrometry (MS/MS) is reported for profiling the phosphoproteome of a complex sample. In this method, an mRP-C18 column was used to frac...

ORGANISM(S): Homo sapiens (Human)

2014-07-24 | PXD000948 | Pride

Phosphoproteome Mrp-rplc Scx-rplc Mda-mb-231 Mass spectrometry

Previous page
1 / 39
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 39
Next page

Sort by:

Relevance

Page size

388 Results

Show results for

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

Metabolite Name

Modification

Release Date

Lab affiliation

OmicsDI is part of the ELIXIR infrastructure

Tweets